Publications by authors named "Paolo Marchetti"

100Publications

Network Analysis of Gut Microbiome and Metabolome to Discover Microbiota-Linked Biomarkers in Patients Affected by Non-Small Cell Lung Cancer.

Int J Mol Sci 2020 Nov 19;21(22). Epub 2020 Nov 19.

Department of Diagnostic and Laboratory Medicine, Unit of Parasitology and Area of Genetics and Rare Diseases, Unit of Human Microbiome, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms21228730DOI Listing
November 2020

Exploratory Pilot Study of Circulating Biomarkers in Metastatic Renal Cell Carcinoma.

Cancers (Basel) 2020 Sep 14;12(9). Epub 2020 Sep 14.

Laboratory of Tumor Immunology and Cell Therapy, Department of Experimental Medicine, Policlinico Umberto I, "Sapienza" University of Rome, 00161 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers12092620DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563741PMC
September 2020

Management of myelofibrosis and concomitant advanced cutaneous squamous cell carcinoma with ruxolitinib associated with cemiplimab.

Ann Hematol 2020 Aug 27. Epub 2020 Aug 27.

Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto 1, Sapienza University, Via Benevento 6, 00161, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-020-04236-7DOI Listing
August 2020

Gynecological and reproductive factors and the risk of pancreatic cancer: A case-control study.

Pancreatology 2020 Sep 31;20(6):1149-1154. Epub 2020 Jul 31.

Digestive and Liver Disease Unit, Sant'Andrea Hospital, Faculty of Medicine and Psychology, Sapienza University of Rome, Milan, Italy; Pancreatobiliary Endoscopy and Endosonography Division, Pancreas Translational and Clinical Research Center, San Raffaele Hospital, San Raffaele Scientific Institute IRCCS, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pan.2020.07.398DOI Listing
September 2020

Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes.

Clin Lung Cancer 2020 Nov 21;21(6):498-508.e2. Epub 2020 Jun 21.

Medical Oncology, St Salvatore Hospital, L'Aquila, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2020.06.010DOI Listing
November 2020

Immunotherapy in the Treatment of Metastatic Melanoma: Current Knowledge and Future Directions.

J Immunol Res 2020 28;2020:9235638. Epub 2020 Jun 28.

Department of Sense Organs, Sapienza University of Rome, Viale del Policlinico 155-00161 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2020/9235638DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338969PMC
June 2020

The 5-Ws of immunotherapy in head and neck cancer.

Crit Rev Oncol Hematol 2020 Sep 30;153:103041. Epub 2020 Jun 30.

Department of Clinical and Molecular Medicine, "Sapienza" University of Rome, Viale Regina Elena 326, 00161, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2020.103041DOI Listing
September 2020

Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50.

Cancer Immunol Immunother 2020 Nov 30;69(11):2209-2221. Epub 2020 May 30.

Medical Oncology, St. Salvatore Hospital, L'Aquila, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-020-02613-9DOI Listing
November 2020

Status of correlation between BMI and response to immunocheck-point inhibitor in advanced non-small-cell lung cancer.

Lung Cancer Manag 2020 Feb 25;9(2):LMT26. Epub 2020 Feb 25.

Medical Oncology Unit, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/lmt-2019-0016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186849PMC
February 2020

Radiopharmaceuticals for Breast Cancer and Neuroendocrine Tumors: Two Examples of How Tissue Characterization May Influence the Choice of Therapy.

Cancers (Basel) 2020 Mar 25;12(4). Epub 2020 Mar 25.

Oncology Unit, Department of Clinical and Molecular Medicine, "Sapienza" University of Rome, and IDI-IRCCS, 00189 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers12040781DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226069PMC
March 2020

5-Fluorouracil degradation rate as a predictive biomarker of toxicity in breast cancer patients treated with capecitabine.

J Oncol Pharm Pract 2020 Mar 4:1078155220904999. Epub 2020 Mar 4.

Department of Medical Oncology, St Andrea University Hospital, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155220904999DOI Listing
March 2020

Adding pertuzumab to adjuvant therapy for high-risk HER2-positive early breast cancer in APHINITY: a GRADE analysis.

J Comp Eff Res 2020 04 14;9(6):423-430. Epub 2020 Feb 14.

Department of Clinical & Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, 00189 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/cer-2019-0168DOI Listing
April 2020

The Fascinating Chemistry of α-Haloamides.

ChemistryOpen 2020 Feb 13;9(2):100-170. Epub 2020 Jan 13.

Department of Chemical and Pharmaceutical Sciences University of Ferrara, Via Fossato di Mortara 17 44121 Ferrara Italy E-mail: V. Zanirato.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/open.201900220DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996577PMC
February 2020

[Immunotherapy in non-small cell lung cancer patients: back to the future.]

Recenti Prog Med 2019 12;110(12):587-593

Azienda Ospedaliero-Universitaria Sant'Andrea, Roma - Azienda Ospedaliero-Universitaria Policlinico Umberto I, Roma.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1701/3278.32517DOI Listing
December 2019

'Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation' by Braaten : another point of view.

Ann Rheum Dis 2020 Jan 6. Epub 2020 Jan 6.

Arthritis Center, Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma, Sapienza University of Rome, Roma, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2019-216867DOI Listing
January 2020

Thyroid disorders in programmed death 1 inhibitor-treated patients: Is previous therapy with tyrosine kinase inhibitors a predisposing factor?

Clin Endocrinol (Oxf) 2020 03 1;92(3):258-265. Epub 2020 Jan 1.

Department of Experimental Medicine, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cen.14135DOI Listing
March 2020

Response to: Comment on "Impact of tumor site on the prognosis of small bowel adenocarcinoma".

Tumori 2019 12 30;105(6):532. Epub 2019 Sep 30.

Department of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0300891619878898DOI Listing
December 2019

Sometimes, the Least Demanding Solution Is the Most Suitable: A Careful Survey of NMR Spectra of a Phosphonium Salt Accounted for Its "Unusual Wittig Reaction".

ACS Omega 2018 Jul 19;3(7):8091-8096. Epub 2018 Jul 19.

Department of Chemical and Pharmaceutical Sciences, University of Ferrara, Via Fossato di Mortara 17, I-44121 Ferrara, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acsomega.8b01228DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6644793PMC
July 2018

Drug resistance of BRAF-mutant melanoma: Review of up-to-date mechanisms of action and promising targeted agents.

Eur J Pharmacol 2019 Nov 22;862:172621. Epub 2019 Aug 22.

Department of Clinical and Molecular Medicine, Oncology Unit, Sant'Andrea Hospital, University "La Sapienza", Rome, Italy; Oncology Unit, IDI-IRCCS of Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejphar.2019.172621DOI Listing
November 2019

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.

Int J Cancer 2020 04 7;146(7):1917-1929. Epub 2019 Aug 7.

Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.32583DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027476PMC
April 2020

Unexpected serious aplastic anemia from PD-1 inhibitors: beyond what we know.

Tumori 2019 Dec 21;105(6):NP48-NP51. Epub 2019 Jun 21.

Medical Oncology Unit, Azienda Ospedaliera Universitaria Sant'Andrea, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0300891619856197DOI Listing
December 2019

[Symptom assessment and chemical coping detection: the assessment of the cancer patient's symptoms between consumption, use and abuse.]

Recenti Prog Med 2019 Mar;110(3):115-117

Oncologia Medica, Azienda Ospedaliero-Universitaria Sant'Andrea, Roma - Oncologia Medica B, Policlinico Umberto I , Roma.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1701/3132.31137DOI Listing
March 2019

Impact of tumor site on the prognosis of small bowel adenocarcinoma.

Tumori 2019 Dec 1;105(6):524-528. Epub 2019 Apr 1.

Department of Molecular and Clinical Medicine, "Sapienza" University of Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0300891619839297DOI Listing
December 2019

Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy: The Galectin-3 Signature in NSCLCs.

Int J Mol Sci 2019 Mar 31;20(7). Epub 2019 Mar 31.

Department of Oncology-Pathology Sant'Andrea University Hospital, via di Grottarossa 1035, 00189 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms20071607DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479404PMC
March 2019

Study of histopathologic parameters to define the prognosis of stage II colon cancer.

Int J Colorectal Dis 2019 May 26;34(5):905-913. Epub 2019 Mar 26.

Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, University "La Sapienza", Rome, Italy.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00384-019-03279-1
Publisher Site
http://dx.doi.org/10.1007/s00384-019-03279-1DOI Listing
May 2019

Dihydroartemisinin-Bile Acid Hybridization as an Effective Approach to Enhance Dihydroartemisinin Anticancer Activity.

ChemMedChem 2019 04;14(7):779-787

Institute of Organic Synthesis and Photoreactivity, National Research Council, Via P. Gobetti 101, 40129, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cmdc.201800756DOI Listing
April 2019

Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a survey about Italian physicians' practice.

Support Care Cancer 2019 Sep 26;27(9):3531-3535. Epub 2019 Jan 26.

Medical Oncology, Department of Biotechnological and Applied Clinical Sciences, St. Salvatore Hospital, L'Aquila, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-019-4663-1DOI Listing
September 2019

Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience.

J Cell Physiol 2019 06 10;234(6):7708-7717. Epub 2018 Dec 10.

Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/jcp.27832
Publisher Site
http://dx.doi.org/10.1002/jcp.27832DOI Listing
June 2019

Factors influencing the use of opioids for breakthrough cancer pain: A secondary analysis of the IOPS-MS study.

Eur J Pain 2019 Apr 28;23(4):719-726. Epub 2018 Dec 28.

Department of Applied Clinical Sciences and Biotechnology, University of L'Aquila, L'Aquila, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ejp.1339
Publisher Site
http://dx.doi.org/10.1002/ejp.1339DOI Listing
April 2019